Estimated antiretroviral therapy coverage among people living with HIV in WPR
WPR: Estimated antiretroviral therapy coverage among people living with HIV was 71.0% in 2025. ◆ Volatile
Estimated antiretroviral therapy coverage among people living with HIV in WPR, 2000–2025
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for estimated antiretroviral therapy coverage among people living with hiv in WPR is 71.0%, measured in 2025. That is the highest value across all 26 years on record.
The figure is up 2.9% on the previous year and up 136.7% over ten years.
Over the whole period, estimated antiretroviral therapy coverage among people living with hiv in WPR peaked at 71.0% in 2025 and was at its lowest, 1.0%, in 2000.
The series is highly variable year to year, so single readings are best treated with caution.
Estimated antiretroviral therapy coverage among people living with HIV in WPR, year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 1.0% | — |
| 2001 | 1.0% | +0.0% |
| 2002 | 1.0% | +0.0% |
| 2003 | 2.0% | +100.0% |
| 2004 | 2.0% | +0.0% |
| 2005 | 4.0% | +100.0% |
| 2006 | 5.0% | +25.0% |
| 2007 | 7.0% | +40.0% |
| 2008 | 8.0% | +14.3% |
| 2009 | 10.0% | +25.0% |
| 2010 | 12.0% | +20.0% |
| 2011 | 15.0% | +25.0% |
| 2012 | 18.0% | +20.0% |
| 2013 | 21.0% | +16.7% |
| 2014 | 25.0% | +19.0% |
| 2015 | 30.0% | +20.0% |
| 2016 | 36.0% | +20.0% |
| 2017 | 41.0% | +13.9% |
| 2018 | 46.0% | +12.2% |
| 2019 | 52.0% | +13.0% |
| 2020 | 56.0% | +7.7% |
| 2021 | 59.0% | +5.4% |
| 2022 | 62.0% | +5.1% |
| 2023 | 65.0% | +4.8% |
| 2024 | 69.0% | +6.2% |
| 2025 | 71.0% | +2.9% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 4.1% | 1.0% | 10.0% | 10 |
| 2010s | 29.6% | 12.0% | 52.0% | 10 |
| 2020s | 63.7% | 56.0% | 71.0% | 6 |
Countries ranked near WPR
More health data for WPR
- Mortality rate among children ages 5 to 9 years 1.24 (2024)
- Population with primary reliance on polluting fuels and technologies 176.35 (2023)
- Population with primary reliance on fuels and technologies for 152.67 (2023)
- Proportion of population with primary reliance on fuels and 23.1% (2023)
- Prevalence of diabetes, crude 12.94 (2022)
- Diphtheria tetanus toxoid and pertussis first-dose (DTP1) 91.0% (2025)
- Measles-containing-vaccine first-dose (MCV1) immunization coverage 89.0% (2025)
- New HIV infections 0.1 (2025)
- BCG immunization coverage among 1-year-olds (%) 92.0% (2025)
- Mean HDL cholesterol, crude 1.3 (2018)
Frequently asked questions
- What is estimated antiretroviral therapy coverage among people living with hiv in WPR?
- Estimated antiretroviral therapy coverage among people living with hiv in WPR was 71.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest estimated antiretroviral therapy coverage among people living with hiv recorded in WPR?
- The highest recorded value was 71.0% in 2025.
- What is the lowest estimated antiretroviral therapy coverage among people living with hiv recorded in WPR?
- The lowest recorded value was 1.0% in 2000.
- How does WPR rank for estimated antiretroviral therapy coverage among people living with hiv?
- WPR ranks 4th out of 13 groups with data for 2025.
- Is estimated antiretroviral therapy coverage among people living with hiv rising or falling in WPR?
- Over the last ten years it is up 136.7%. The long-run trend across the full record is volatile.
- Where does this WPR data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Estimated antiretroviral therapy coverage among people living with HIV (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).